| BIOPHARMA CREDIT PLC | 30/09/2021 EGM | |
|---|---|---|
| 1 | Admission of the ordinary shares in the capital of the Company to trading on the premium segment of the main market of the London Stock Exchange and to listing on the Official List of the Financial Conduct Authority | For |
| 2 | Approval of the Premium Admission Proposals. | For |
| 3 | Amend Articles | For |
| 4 | Approve the Continuation of the Company | For |